A

Apellis Pharmaceuticals

Develops complement inhibition therapies for diseases

Director, Business Intelligence - PNH

Business OperationsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USANo salary listed

About the Job

Requirements

  • A B.S. degree is required; a business, biology, or medicine-related degree is preferred. An advanced degree (MBA, PhD, or PharmD) is preferred.
  • At least 10 years of experience in an insights and analytics function within a biotech or biopharma organization.
  • Experience in rare disease.
  • Strong hands-on analytics and modeling skills in Excel, with familiarity with business intelligence tools such as Power BI.
  • Expertise with claims, electronic medical record, and registry datasets to generate strategic, actionable insights.
  • Expertise in qualitative and quantitative market research methodologies.
  • Project and vendor management skills, with the ability to run multiple cross-disciplinary projects simultaneously, including sales analytics, claims analyses, and market research, with competing timelines.
  • Ability to influence across several organizational levels, including executive leadership, without authority.
  • Strategic and analytical mindset, with strong problem-solving and framing abilities.
  • Ability to integrate insights from multiple sources, create simplicity from complexity, and articulate solution-driven narratives that foster action.
  • Ability to challenge and persuade different cross-functional audiences within the organization, including business and executive leadership.
  • Experience in commercial assessments, asset evaluation, and prioritization.

Responsibilities

  • Own brand performance, sales analytics, and reporting, including national and subnational analyses.
  • Partner with the brand lead and relevant cross-functional stakeholders to design and execute strategic primary market research to track brand performance and address key business questions.
  • Lead business intelligence for strategic brand initiatives, such as brand planning and tactical planning, and provide market outlooks, situation assessments, and SWOT analyses.
  • Develop expert knowledge across the therapeutic area, including the competitive landscape of marketed and pipeline products, market dynamics, customer behavior, and sentiment.
  • Partner with Forecasting, maintain a strong understanding of the forecast, and provide and validate assumptions that inform the brand forecast.
  • Proactively scope key business questions, generate hypotheses, independently design studies and analyses, and generate insights for the business with a strong focus on foresight.
  • Own the annual insights budget for EMPAVELI in PNH.

About the Company

Apellis Pharmaceuticals

Develops complement inhibition therapies for diseases

Apellis Pharmaceuticals develops therapies that target the complement system, a part of the immune system involved in inflammation and disease. The company focuses on complement inhibition to treat rare and debilitating conditions with unmet medical needs. Its approach centers on therapies that precisely modulate the complement cascade to help patients. Apellis went public in 2017 to fund its research and development efforts, and in 2025 it formed a strategic partnership with Sobi to sell ex-US royalties on its drug Aspaveli for up to $300 million, providing capital and expanding global reach. Compared with competitors, Apellis pursues targeted complement modulation and leverages strategic partnerships and royalties to support its growth. The company's goal is to advance effective, targeted treatments that improve the lives of patients worldwide by addressing diseases driven by the complement system.

Company size
501-1,000
Company stage
IPO
Headquarters
Waltham, MA
Founded
2008

Recently Posted Jobs

Explore more opportunities at Apellis Pharmaceuticals

See more jobs